JPS5921615A - 鎮痛剤組成物 - Google Patents
鎮痛剤組成物Info
- Publication number
- JPS5921615A JPS5921615A JP58124059A JP12405983A JPS5921615A JP S5921615 A JPS5921615 A JP S5921615A JP 58124059 A JP58124059 A JP 58124059A JP 12405983 A JP12405983 A JP 12405983A JP S5921615 A JPS5921615 A JP S5921615A
- Authority
- JP
- Japan
- Prior art keywords
- meptazinol
- ibuprofen
- pharmaceutically acceptable
- composition
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8219837 | 1982-07-08 | ||
| GB8219837 | 1982-07-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5921615A true JPS5921615A (ja) | 1984-02-03 |
Family
ID=10531551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58124059A Pending JPS5921615A (ja) | 1982-07-08 | 1983-07-06 | 鎮痛剤組成物 |
Country Status (20)
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015516447A (ja) * | 2012-05-18 | 2015-06-11 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | （１ｒ，４ｒ）−６’−フルオロ−Ｎ，Ｎ−ジメチル−４−フェニル−４’，９’−ジヒドロ−３’Ｈ−スピロ［シクロヘキサン−１，１’−ピラノ−［３，４，ｂ］インドール］−４−アミンおよびプロピオン酸誘導体を含む医薬組成物 |
| US9855286B2 (en) | 2012-05-18 | 2018-01-02 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
| US11311504B2 (en) | 2012-05-18 | 2022-04-26 | Park Therapeutics, Inc. | Pharmaceutical composition comprising (1R,4R)-6′- fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano- [3,4,b ]indol] -4-amine and paracetamol or propacetamol |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6348216B1 (en) * | 1996-06-10 | 2002-02-19 | Knoll Pharmaceutical Company | Ibuprofen and narcotic analgesic compositions |
| US6361794B1 (en) | 1996-06-12 | 2002-03-26 | Basf Corporation | Method of making ibuprofen and narcotic analgesic composition |
| TW200800223A (en) * | 2005-12-21 | 2008-01-01 | Shire Pharmaceuticals Inc | Transdermal delivery of meptazinol |
| JP2010501001A (ja) * | 2006-08-14 | 2010-01-14 | シャイア ファーマシューティカルズ インコーポレイテッド | メプタジノールの経皮送達 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB971700A (en) * | 1961-02-02 | 1964-09-30 | Boots Pure Drug Co Ltd | Anti-Inflammatory Agents |
| GB1285025A (en) * | 1968-08-16 | 1972-08-09 | Wyeth John & Brother Ltd | Hexahydroazepines |
| DE3273329D1 (en) * | 1981-06-26 | 1986-10-23 | Upjohn Co | Analgesic process and composition |
-
1983
- 1983-06-14 IE IE1399/83A patent/IE55189B1/en unknown
- 1983-06-16 AT AT83303478T patent/ATE36455T1/de not_active IP Right Cessation
- 1983-06-16 GB GB08316387A patent/GB2122895B/en not_active Expired
- 1983-06-16 EP EP83303478A patent/EP0099186B1/en not_active Expired
- 1983-06-16 DE DE8383303478T patent/DE3377696D1/de not_active Expired
- 1983-06-17 AU AU15894/83A patent/AU560575B2/en not_active Ceased
- 1983-06-20 ZA ZA834502A patent/ZA834502B/xx unknown
- 1983-06-20 NZ NZ204644A patent/NZ204644A/en unknown
- 1983-06-20 CA CA000430768A patent/CA1194798A/en not_active Expired
- 1983-06-23 IL IL69058A patent/IL69058A/xx not_active IP Right Cessation
- 1983-06-24 GR GR71775A patent/GR78605B/el unknown
- 1983-06-28 PH PH29131A patent/PH18649A/en unknown
- 1983-06-28 AR AR293464A patent/AR230571A1/es active
- 1983-07-01 ZW ZW150/83A patent/ZW15083A1/xx unknown
- 1983-07-01 FI FI832426A patent/FI832426L/fi not_active Application Discontinuation
- 1983-07-05 US US06/510,868 patent/US4466963A/en not_active Expired - Fee Related
- 1983-07-06 JP JP58124059A patent/JPS5921615A/ja active Pending
- 1983-07-07 PT PT76999A patent/PT76999B/pt unknown
- 1983-07-07 HU HU832444A patent/HU186719B/hu unknown
- 1983-07-07 DK DK314283A patent/DK314283A/da not_active Application Discontinuation
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015516447A (ja) * | 2012-05-18 | 2015-06-11 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | （１ｒ，４ｒ）−６’−フルオロ−Ｎ，Ｎ−ジメチル−４−フェニル−４’，９’−ジヒドロ−３’Ｈ−スピロ［シクロヘキサン−１，１’−ピラノ−［３，４，ｂ］インドール］−４−アミンおよびプロピオン酸誘導体を含む医薬組成物 |
| US9855286B2 (en) | 2012-05-18 | 2018-01-02 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
| US10076510B2 (en) | 2012-05-18 | 2018-09-18 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
| US11311504B2 (en) | 2012-05-18 | 2022-04-26 | Park Therapeutics, Inc. | Pharmaceutical composition comprising (1R,4R)-6′- fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano- [3,4,b ]indol] -4-amine and paracetamol or propacetamol |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE36455T1 (de) | 1988-09-15 |
| AR230571A1 (es) | 1984-05-31 |
| US4466963A (en) | 1984-08-21 |
| ZW15083A1 (en) | 1985-01-23 |
| DK314283A (da) | 1984-01-09 |
| HU186719B (en) | 1985-09-30 |
| FI832426A0 (fi) | 1983-07-01 |
| DK314283D0 (da) | 1983-07-07 |
| PH18649A (en) | 1985-08-23 |
| NZ204644A (en) | 1985-09-13 |
| EP0099186B1 (en) | 1988-08-17 |
| DE3377696D1 (en) | 1988-09-22 |
| IE55189B1 (en) | 1990-06-20 |
| GB2122895B (en) | 1986-06-18 |
| GB8316387D0 (en) | 1983-07-20 |
| GB2122895A (en) | 1984-01-25 |
| GR78605B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-09-27 |
| FI832426A7 (fi) | 1984-01-09 |
| FI832426L (fi) | 1984-01-09 |
| AU1589483A (en) | 1984-01-12 |
| PT76999A (en) | 1983-08-01 |
| EP0099186A3 (en) | 1984-11-07 |
| AU560575B2 (en) | 1987-04-09 |
| EP0099186A2 (en) | 1984-01-25 |
| IE831399L (en) | 1984-01-08 |
| PT76999B (en) | 1986-02-27 |
| IL69058A (en) | 1985-12-31 |
| CA1194798A (en) | 1985-10-08 |
| IL69058A0 (en) | 1983-10-31 |
| ZA834502B (en) | 1985-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4066756A (en) | Therapeutic compositions of 1,3-bis(2-carboxychromon-5-yloxyl)propan-2-ol and aspirin or indomethacin | |
| EP0185420B1 (en) | Dihydrocodeine/ibuprofen pharmaceutical compositions and method | |
| AU606149B2 (en) | Pharmaceutical formulations | |
| JPS60208913A (ja) | 高めた無痛覚を与える製薬製品 | |
| HU202404B (en) | Process for producing pharmaceutical compositions containing dipyridamol or mopidamol and o-acetyl-salicylic acid or salts thereof | |
| CA1267847A (en) | Hydrocodone/ibuprofen pharmaceutical compositions and method | |
| US4590213A (en) | Anti-anxiety method | |
| KR20000064757A (ko) | 5-메틸이속사졸-4-카복실산-(4-트리플루오로메틸)-아닐리드 및n-(4-트리플루오로메틸페닐)-2-시아노-3-하이드록시크로톤산아미드의 배합물을 함유하는 제제 | |
| CN106456637B (zh) | (s)-吡吲哚及其药学上可接受的盐的药学用途 | |
| SE466481B (sv) | Analgetiska och anti-inflammatoriska kompositioner innefattande koffein | |
| JPS5921615A (ja) | 鎮痛剤組成物 | |
| US4576951A (en) | Proglumide, pharmaceutical preparations and compositions including it for use in human pain relief | |
| JPS5938203B2 (ja) | 補酵素ｑを主成分とする脳循環障害治療剤 | |
| US4730007A (en) | Novel analgesic compositions | |
| JPS5940134B2 (ja) | 抗血栓性医薬組成物 | |
| JPH0140009B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| CZ79593A3 (en) | Antitussive preparation | |
| US4686225A (en) | Vinpocetine for pulmonary hemorrhage and edema | |
| JPH0651669B2 (ja) | 抗炎症及び鎮痛活性を有する化合物及び組成物 | |
| US3360434A (en) | Method for reducing blood pressure with phenylalanine derivatives | |
| JP2627914B2 (ja) | プロスタグランジン類の選択的作用増強剤 | |
| JPH01221316A (ja) | 脳循環代謝改善剤 | |
| CA1141664A (en) | Analgesic composition | |
| US3914425A (en) | Antitussive codeine composition | |
| JPH0232020A (ja) | モルフィン鎮痛治療における耐性発現の抑制方法および薬剤 |